State Drug Administration: the second batch of national key laboratories public list

Pharma Network January 26 - According to the relevant provisions of the Measures for the Administration of Key Laboratories of the State Drug Administration (No. 56 of the State Drug Administration(2019), the State Drug Administration has drawn up a list of key laboratories for publicity from January 22 to January 28, 2021, after voluntary application by the relying units, preliminary verification recommendations by the local provincial drug regulatory departments, formal examination, defense review, on-site verification and comprehensive evaluation.
publicity period, if there is any objection to the object of publicity, it may be reported to the State Drug Administration.
materials reflecting the situation in the name of the unit shall be stamped with the official seal of the unit, and the materials reflecting the situation in the name of the individual shall have a real name and with contact information.
materials reflecting the situation should be objective, accurate, well-founded, anonymous or unfounded reports, inadmissible.
: Tao Yamin Contact: 010-88331105 E-mail: kbskjc@nmpa.gov.cn Address: Beijing Xicheng Exhibition Road, North Luyuan 1 Building, State Drug Administration Postcode of the Division of Science, Technology and International Cooperation: Annex: Annex 100037: The second batch of key laboratories of the State Drug Administration made public the list of key laboratories of the Division of Science, Technology and International Cooperation by 22 January 2021 Annex: The second batch of key laboratories passed the list of judges